Effects of lobectomy versus sub-lobar resection on the survival in adults with stage IA left upper lobe non-small cell lung cancer: a retrospective cohort study based on the SEER database

医学 危险系数 回顾性队列研究 内科学 全肺切除术 比例危险模型 肺癌 数据库 优势比 阶段(地层学) 监测、流行病学和最终结果 肿瘤科 倾向得分匹配 单变量分析 外科 队列 流行病学 置信区间 癌症登记处 多元分析 古生物学 生物 计算机科学
作者
Huanshun Wen,Chaoyang Liang
出处
期刊:Oncology [S. Karger AG]
标识
DOI:10.1159/000534195
摘要

To compare the survival after lobectomy (LR) and sub-lobar resection (SLR) of left upper lobe (LUL) among non-small cell lung cancer (NSCLC) patients with stage IA.This retrospective cohort research analyzed public data collected by the Surveillance, Epidemiology, and End Results (SEER) database. Tumor characteristics were determined based on the International Classification of Diseases for Oncology, 3rd edition (ICD-O-3). Propensity score matching (PSM) analysis was performed with a ratio of 1:1. Univariate and multivariable Cox proportional regression analyses were used to assess the effects of LR and SLR on the survival of the patients, with hazard ratios (HRs) and 95% confidence intervals (95%CIs). The effects were further evaluated by different subgroups of age, gender, tumor grades, histologic types, T stages.Of the total 2,649 patients, 1,907 underwent the LR and 742 received SLR. Totally 998 patients died at the end of the follow-up. The median survival time of all patients were 66 (49, 87) months. After adjusting the age, gender, race, tumor grade, histologic type, T stage, examined lymph nodes, radiation, and chemotherapy, NSCLC patients with stage IA who received SLR had higher odds of death in comparison with these patients who received LR (HR=1.424, 95%CI: 1.227-1.652). After PSM, SLR was associated with higher odds of death in the patients (HR=1.35, 95%CI: 1.10-1.66). Similar results were discovered in different subpopulations.The SLR was inferior to LR on the survival of NSCLC patients with stage IA.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
酷波er应助sci大户采纳,获得10
刚刚
ding应助DrLee采纳,获得10
刚刚
刚刚
SciGPT应助刘丰铭采纳,获得10
刚刚
qitengzhu发布了新的文献求助10
刚刚
刘霆勋发布了新的文献求助10
刚刚
英姑应助SY采纳,获得10
1秒前
小张同学发布了新的文献求助10
2秒前
3秒前
司藤完成签到 ,获得积分10
3秒前
隐形曼青应助wanduzi采纳,获得10
4秒前
Hello应助一杯甜酒采纳,获得10
4秒前
4秒前
忧伤的觅珍完成签到,获得积分10
6秒前
6秒前
李hy发布了新的文献求助10
7秒前
研友_VZG7GZ应助刘霆勋采纳,获得10
7秒前
科研通AI6应助李俊杰采纳,获得30
8秒前
8秒前
秘密发布了新的文献求助10
8秒前
8秒前
8秒前
情怀应助好名字采纳,获得10
9秒前
9秒前
xiaolv应助能干可乐采纳,获得10
9秒前
10秒前
量子星尘发布了新的文献求助10
10秒前
gngxnh完成签到 ,获得积分10
10秒前
酷酷问薇发布了新的文献求助10
11秒前
11秒前
11秒前
11秒前
jm完成签到,获得积分10
11秒前
张紫嫣完成签到,获得积分10
11秒前
11秒前
怪诞奇男子完成签到,获得积分10
11秒前
12秒前
ss发布了新的文献求助10
12秒前
郑嘻嘻发布了新的文献求助10
12秒前
薄荷778发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
人脑智能与人工智能 1000
花の香りの秘密―遺伝子情報から機能性まで 800
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
Pharmacology for Chemists: Drug Discovery in Context 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5608292
求助须知:如何正确求助?哪些是违规求助? 4692876
关于积分的说明 14875899
捐赠科研通 4717214
什么是DOI,文献DOI怎么找? 2544162
邀请新用户注册赠送积分活动 1509147
关于科研通互助平台的介绍 1472809